chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Chills, Diarrhoea, Nausea
Clinical narrative: same reaction that she had 4 weeks ago; Chills; Diarrhea; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (same reaction that she had 4 weeks ago), CHILLS (Chills), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ADVERSE REACTION (same reaction that she had 4 weeks ago), CHILLS (Chills), DIARRHOEA (Diarrhea) and NAUSEA (Nausea). At the time of the report, ADVERSE REACTION (same reaction that she had 4 weeks ago), CHILLS (Chills), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Pyrexia
Clinical narrative: chills; uncontrollable body shaking; uncontrollable hands shaking; fever; fatigue; sore arm; body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLONAZEPAM, MACROGOL 3350 (MIRALAX), CALCIUM and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever), FATIGUE (fatigue), PAIN IN EXTREMITY (sore arm) and PAIN (body ache). At the time of the report, CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever), FATIGUE (fatigue), PAIN IN EXTREMITY (sore arm) and PAIN (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: chills; uncontrollable body shaking; uncontrollable hands shaking; fever; fatigue; sore arm; body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLONAZEPAM, MACROGOL 3350 (MIRALAX), CALCIUM and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever), FATIGUE (fatigue), PAIN IN EXTREMITY (sore arm) and PAIN (body ache). At the time of the report, CHILLS (chills), TREMOR (uncontrollable body shaking), TREMOR (uncontrollable hands shaking), PYREXIA (fever), FATIGUE (fatigue), PAIN IN EXTREMITY (sore arm) and PAIN (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Tremor, Urticaria
Clinical narrative: Hives; Chills; Shakiness; Achy; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), CHILLS (Chills), TREMOR (Shakiness) and PAIN (Achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included birth control pills for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives), CHILLS (Chills), TREMOR (Shakiness) and PAIN (Achy). At the time of the report, URTICARIA (Hives), CHILLS (Chills), TREMOR (Shakiness) and PAIN (Achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HYPERSENSITIVITY (allergic reaction). At the time of the report, HYPERSENSITIVITY (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Dyspnoea, Eye pain, Headache, Myalgia
Clinical narrative: headache; Pain in both eyes above the eye lids; trouble breathing; body aches; Left side hurts from my head to my big toe; obstruction in my throat; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches) and PAIN (Left side hurts from my head to my big toe) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches), PAIN (Left side hurts from my head to my big toe) and DYSPHAGIA (obstruction in my throat). At the time of the report, HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches), PAIN (Left side hurts from my head to my big toe) and DYSPHAGIA (obstruction in my throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: headache; Pain in both eyes above the eye lids; trouble breathing; body aches; Left side hurts from my head to my big toe; obstruction in my throat; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches) and PAIN (Left side hurts from my head to my big toe) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches), PAIN (Left side hurts from my head to my big toe) and DYSPHAGIA (obstruction in my throat). At the time of the report, HEADACHE (headache), EYE PAIN (Pain in both eyes above the eye lids), DYSPNOEA (trouble breathing), MYALGIA (body aches), PAIN (Left side hurts from my head to my big toe) and DYSPHAGIA (obstruction in my throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pruritus, Urticaria
Clinical narrative: mild itch; raised welt; mild injection site tenderness; mild injection site pain; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE PAIN (mild injection site pain), PRURITUS (mild itch), URTICARIA (raised welt) and INJECTION SITE PAIN (mild injection site tenderness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included Tylenol                                                        as needed and LEVOTHYROXINE for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE PAIN (mild injection site pain) and INJECTION SITE PAIN (mild injection site tenderness). On 17-Feb-2021, the patient experienced PRURITUS (mild itch) and URTICARIA (raised welt). At the time of the report, INJECTION SITE PAIN (mild injection site pain), PRURITUS (mild itch), URTICARIA (raised welt) and INJECTION SITE PAIN (mild injection site tenderness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2021: Followup was received on 20-Jun-2021. No new information was present in source document.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Device connection issue
Clinical narrative: Adverse effect; Vaccine rolled out of arm; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse effect) and DEVICE CONNECTION ISSUE (Vaccine rolled out of arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DEVICE CONNECTION ISSUE (Vaccine rolled out of arm). On an unknown date, the patient experienced ADVERSE REACTION (Adverse effect). On 27-Jan-2021, DEVICE CONNECTION ISSUE (Vaccine rolled out of arm) had resolved. At the time of the report, ADVERSE REACTION (Adverse effect) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Apr-2021: Non significant information added. On 23-Jul-2021: Follow up received: lot number, start date of vaccine and outcome of event added.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest pain, Cough, Headache, Malaise
Clinical narrative: symptoms very similar to covid; headache; chest pain; cough; general malaise; nauseate; stomach upset; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (symptoms very similar to covid), HEADACHE (headache), CHEST PAIN (chest pain), COUGH (cough) and MALAISE (general malaise) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE and PROPRANOLOL for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SUSPECTED COVID-19 (symptoms very similar to covid), HEADACHE (headache), CHEST PAIN (chest pain), COUGH (cough), MALAISE (general malaise), NAUSEA (nauseate) and ABDOMINAL DISCOMFORT (stomach upset). At the time of the report, SUSPECTED COVID-19 (symptoms very similar to covid), HEADACHE (headache), CHEST PAIN (chest pain), COUGH (cough), MALAISE (general malaise), NAUSEA (nauseate) and ABDOMINAL DISCOMFORT (stomach upset) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Suspected COVID-19
Clinical narrative: symptoms very similar to covid; headache; chest pain; cough; general malaise; nauseate; stomach upset; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (symptoms very similar to covid), HEADACHE (headache), CHEST PAIN (chest pain), COUGH (cough) and MALAISE (general malaise) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE and PROPRANOLOL for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SUSPECTED COVID-19 (symptoms very similar to covid), HEADACHE (headache), CHEST PAIN (chest pain), COUGH (cough), MALAISE (general malaise), NAUSEA (nauseate) and ABDOMINAL DISCOMFORT (stomach upset). At the time of the report, SUSPECTED COVID-19 (symptoms very similar to covid), HEADACHE (headache), CHEST PAIN (chest pain), COUGH (cough), MALAISE (general malaise), NAUSEA (nauseate) and ABDOMINAL DISCOMFORT (stomach upset) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Pyrexia
Clinical narrative: Low grade fever; Chills; Nausea; Really super super bad dizziness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever), CHILLS (Chills), NAUSEA (Nausea) and DIZZINESS (Really super super bad dizziness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PYREXIA (Low grade fever), CHILLS (Chills), NAUSEA (Nausea) and DIZZINESS (Really super super bad dizziness). At the time of the report, PYREXIA (Low grade fever), CHILLS (Chills), NAUSEA (Nausea) and DIZZINESS (Really super super bad dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash
Clinical narrative: itchy spot on left hand and then it spread across his hand/Itchy spot spread to the other hand; His fingers swelled out; Rash spread to arms/Rash spread to legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy spot on left hand and then it spread across his hand/Itchy spot spread to the other hand), PERIPHERAL SWELLING (His fingers swelled out) and RASH (Rash spread to arms/Rash spread to legs) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Blood thinners and High blood pressure medication for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PRURITUS (itchy spot on left hand and then it spread across his hand/Itchy spot spread to the other hand), PERIPHERAL SWELLING (His fingers swelled out) and RASH (Rash spread to arms/Rash spread to legs). At the time of the report, PRURITUS (itchy spot on left hand and then it spread across his hand/Itchy spot spread to the other hand), PERIPHERAL SWELLING (His fingers swelled out) and RASH (Rash spread to arms/Rash spread to legs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Injection site erythema, Injection site reaction, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: COVID arm; Hot and little swelling; Injection site was pretty large; Injection site red again; Arm started to hearting again; Kind of hard; Burns a little bit; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (COVID arm), PAIN IN EXTREMITY (Arm started to hearting again), MUSCULOSKELETAL STIFFNESS (Kind of hard), BURNING SENSATION (Burns a little bit) and SWELLING (Hot and little swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hearting again), MUSCULOSKELETAL STIFFNESS (Kind of hard), BURNING SENSATION (Burns a little bit), INJECTION SITE REACTION (Injection site was pretty large) and INJECTION SITE ERYTHEMA (Injection site red again). On an unknown date, the patient experienced UNEVALUABLE EVENT (COVID arm) and SWELLING (Hot and little swelling). At the time of the report, UNEVALUABLE EVENT (COVID arm), PAIN IN EXTREMITY (Arm started to hearting again), MUSCULOSKELETAL STIFFNESS (Kind of hard), BURNING SENSATION (Burns a little bit), SWELLING (Hot and little swelling), INJECTION SITE REACTION (Injection site was pretty large) and INJECTION SITE ERYTHEMA (Injection site red again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Unevaluable event
Clinical narrative: COVID arm; Hot and little swelling; Injection site was pretty large; Injection site red again; Arm started to hearting again; Kind of hard; Burns a little bit; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (COVID arm), PAIN IN EXTREMITY (Arm started to hearting again), MUSCULOSKELETAL STIFFNESS (Kind of hard), BURNING SENSATION (Burns a little bit) and SWELLING (Hot and little swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hearting again), MUSCULOSKELETAL STIFFNESS (Kind of hard), BURNING SENSATION (Burns a little bit), INJECTION SITE REACTION (Injection site was pretty large) and INJECTION SITE ERYTHEMA (Injection site red again). On an unknown date, the patient experienced UNEVALUABLE EVENT (COVID arm) and SWELLING (Hot and little swelling). At the time of the report, UNEVALUABLE EVENT (COVID arm), PAIN IN EXTREMITY (Arm started to hearting again), MUSCULOSKELETAL STIFFNESS (Kind of hard), BURNING SENSATION (Burns a little bit), SWELLING (Hot and little swelling), INJECTION SITE REACTION (Injection site was pretty large) and INJECTION SITE ERYTHEMA (Injection site red again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: event that occurred the evening she got the second shot. It has been re-occurring since then; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (event that occurred the evening she got the second shot. It has been re-occurring since then) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (event that occurred the evening she got the second shot. It has been re-occurring since then). At the time of the report, ADVERSE EVENT (event that occurred the evening she got the second shot. It has been re-occurring since then) outcome was unknown.            This case was linked to MOD-2021-030826 (Patient Link).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site warmth, Joint swelling, Peripheral swelling, Pruritus
Clinical narrative: Swollen Arm; Arm was hot to touch; Swelling has moved to wrist; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), PERIPHERAL SWELLING (Swollen Arm), INJECTION SITE WARMTH (Arm was hot to touch) and JOINT SWELLING (Swelling has moved to wrist) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced PRURITUS (Itchiness). On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen Arm), INJECTION SITE WARMTH (Arm was hot to touch) and JOINT SWELLING (Swelling has moved to wrist). On 16-Jan-2021, PRURITUS (Itchiness) had resolved. On 16-Feb-2021, PERIPHERAL SWELLING (Swollen Arm) and JOINT SWELLING (Swelling has moved to wrist) had resolved. At the time of the report, INJECTION SITE WARMTH (Arm was hot to touch) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Pain
Clinical narrative: elbow swelling; pain which is still ongoing; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (elbow swelling) and PAIN (pain which is still ongoing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 12-Feb-2021, the patient experienced JOINT SWELLING (elbow swelling) and PAIN (pain which is still ongoing). At the time of the report, JOINT SWELLING (elbow swelling) and PAIN (pain which is still ongoing) outcome was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: rapid heartrate that went up to 185 BPM; her heartrate was between 88-99 BPM; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (rapid heartrate that went up to 185 BPM) and TACHYCARDIA (her heartrate was between 88-99 BPM) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced TACHYCARDIA (rapid heartrate that went up to 185 BPM) and TACHYCARDIA (her heartrate was between 88-99 BPM). On 06-Feb-2021, TACHYCARDIA (rapid heartrate that went up to 185 BPM) had resolved. At the time of the report, TACHYCARDIA (her heartrate was between 88-99 BPM) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pruritus
Clinical narrative: Pain in the muscle, upper arm; itchy arm; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), PRURITUS (itchy arm) and MYALGIA (Pain in the muscle, upper arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (soreness). On 17-Feb-2021, the patient experienced PRURITUS (itchy arm). On an unknown date, the patient experienced MYALGIA (Pain in the muscle, upper arm). At the time of the report, PAIN (soreness), PRURITUS (itchy arm) and MYALGIA (Pain in the muscle, upper arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Minor pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Minor pain at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PAIN (Minor pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Minor pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Nausea
Clinical narrative: Nausea; Headache; Weakness; Chills; Feels Off"; Fever; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills) and FATIGUE (Feels Off") in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), Emotrol and ONDANSETRON (ZOFRAN MELT) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills), FATIGUE (Feels Off") and PYREXIA (Fever). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills), FATIGUE (Feels Off") and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Nausea; Headache; Weakness; Chills; Feels Off"; Fever; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills) and FATIGUE (Feels Off") in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), Emotrol and ONDANSETRON (ZOFRAN MELT) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills), FATIGUE (Feels Off") and PYREXIA (Fever). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills), FATIGUE (Feels Off") and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Couple of us in our office received the moderna vaccine and had the COVID arm; rash; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Couple of us in our office received the moderna vaccine and had the COVID arm) and RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Couple of us in our office received the moderna vaccine and had the COVID arm) and RASH (rash). At the time of the report, PAIN IN EXTREMITY (Couple of us in our office received the moderna vaccine and had the COVID arm) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Pruritus, Rash macular, Rash papular
Clinical narrative: Raised; Itchiness; Redness; Firmness; Sore; Red Spot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH MACULAR (Red Spot), ERYTHEMA (Redness), PRURITUS (Itchiness), MYALGIA (Firmness) and RASH PAPULAR (Raised) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced RASH MACULAR (Red Spot). On 16-Feb-2021, the patient experienced ERYTHEMA (Redness), PRURITUS (Itchiness), MYALGIA (Firmness), RASH PAPULAR (Raised) and MYALGIA (Sore). The patient was treated with HYDROCORTISON [HYDROCORTISONE] at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Red Spot), ERYTHEMA (Redness), PRURITUS (Itchiness), MYALGIA (Firmness), RASH PAPULAR (Raised) and MYALGIA (Sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Ice.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chills, Insomnia, Pain
Clinical narrative: aches and chills; aches and chills; problem sleeping; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (problem sleeping), PAIN (aches and chills) and CHILLS (aches and chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced INSOMNIA (problem sleeping). On 13-Feb-2021, the patient experienced PAIN (aches and chills) and CHILLS (aches and chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INSOMNIA (problem sleeping), PAIN (aches and chills) and CHILLS (aches and chills) outcome was unknown.            Reporter did not allow further contact
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: pain in that arm ever since the injection; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in that arm ever since the injection) and ARTHRALGIA (Joint pain) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 011M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced ARTHRALGIA (Joint pain). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in that arm ever since the injection). At the time of the report, PAIN IN EXTREMITY (pain in that arm ever since the injection) and ARTHRALGIA (Joint pain) outcome was unknown.            Reporter did not allow further contact
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: rash at injection site/ rash increased in size over three days; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash at injection site/ rash increased in size over three days) and INJECTION SITE PRURITUS (itching at the injection site) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE RASH (rash at injection site/ rash increased in size over three days) and INJECTION SITE PRURITUS (itching at the injection site). At the time of the report, INJECTION SITE RASH (rash at injection site/ rash increased in size over three days) and INJECTION SITE PRURITUS (itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Reporter's Comments: Based on the established safety profile and a strong temporal association between the reported events and administration of mRNA-1273 vaccine, a causal association cannot be excluded.  The events are consistent with the known safety profile of the vaccine.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for COVID19). At the time of the report, COVID-19 (tested positive for COVID19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029620A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 16-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Nausea
Clinical narrative: Felt weak for 3 to 4 days; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt weak for 3 to 4 days) and NAUSEA (Nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 29L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ASTHENIA (Felt weak for 3 to 4 days) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Felt weak for 3 to 4 days) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse reactions) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced ADVERSE EVENT (Adverse reactions). At the time of the report, ADVERSE EVENT (Adverse reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant information provided. No treatment information provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: it's hot there; fatigue; headache; swelling; beet red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (it's hot there), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (beet red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (beet red). On 17-Feb-2021, the patient experienced VACCINATION SITE WARMTH (it's hot there), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, VACCINATION SITE WARMTH (it's hot there), FATIGUE (fatigue), HEADACHE (headache), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (beet red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. Treatment included Zyrtec, Cold Compress, Tylenol
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscular weakness, Pain in extremity
Clinical narrative: leg weakness; arm soreness; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (leg weakness), PAIN IN EXTREMITY (arm soreness) and HEADACHE (headache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN and ENALAPRIL for an unknown indication.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and HEADACHE (headache). On 17-Feb-2021, the patient experienced MUSCULAR WEAKNESS (leg weakness). On 17-Feb-2021, PAIN IN EXTREMITY (arm soreness) and HEADACHE (headache) had resolved. At the time of the report, MUSCULAR WEAKNESS (leg weakness) outcome was unknown.            No treatment information provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash
Clinical narrative: rash on other arm; rash on abdomen/rash on upper thighs; rash on arm at injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (rash on other arm), RASH (rash on abdomen/rash on upper thighs) and INJECTION SITE RASH (rash on arm at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced RASH (rash on other arm), RASH (rash on abdomen/rash on upper thighs) and INJECTION SITE RASH (rash on arm at injection site). At the time of the report, RASH (rash on other arm), RASH (rash on abdomen/rash on upper thighs) and INJECTION SITE RASH (rash on arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Chills; Body Aches; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Body Aches), HEADACHE (Headache) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (Body Aches), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, CHILLS (Chills), MYALGIA (Body Aches), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vomiting
Clinical narrative: throwing up; having chills; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (throwing up) and CHILLS (having chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VOMITING (throwing up) and CHILLS (having chills). At the time of the report, VOMITING (throwing up) and CHILLS (having chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment and concomitant drugs are provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Developed a rash on chest, back, and legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced ERYTHEMA (Developed a rash on chest, back, and legs). At the time of the report, ERYTHEMA (Developed a rash on chest, back, and legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact